An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients

被引:85
作者
Engel, A [1 ]
Mack, E [1 ]
Kern, P [1 ]
Kern, WV [1 ]
机构
[1] Univ Ulm, Med Klin & Poliklin, D-89070 Ulm, Germany
关键词
D O I
10.1007/BF02962366
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A prospective study was performed to assess the potential value of interleukin (IL)-8, IL-6, and C-reactive protein (CRP) serum levels to predict fever, gram-negative bacteremia and complicated infection in neutropenic patients with cancer. Serum samples were obtained three times a week during 208 neutropenic episodes following cytotoxic chemotherapy. Fever of any cause developed during 104 out of 191 evaluable episodes. Serum levels of neither cytokine nor CRP were predictive of fever within more than 24 h before its onset. Unlike CRP, both IL-6 and IL-8 serum levels were significantly different between microbiologically documented infections and unexplained fevers. The highest values of IL-6 and IL-8 were observed in episodes of gram-negative bacteremia, Using receiver-operating-characteristic curves, the analysis of cytokine levels measured around the onset of fever indicated that IL-8 is potentially useful for predicting gram-negative bacteremia, with a high negative predictive value of > 90% and a moderate positive predictive value of 50% (sensitivity, 70%; specificity, 91%), In patients with persistent fever, predictions of further clinical complications, defined as prolonged fever of more than 7 days' duration, pneumonia, shock and/or death due to infection, were best predicted by IL-6, With an IL-6 cutoff value of 250 pg/ml in samples obtained 8 to 32 h after onset of fever, the positive predictive value was 92%, the negative predictive value 91% (sensitivity, 85%; specificity, 95%), The positive predictive value of IL-6 in samples obtained another 24 h later from patients still febrile remained > 90%, but the negative predictive value dropped to 47%, In any of the analyses, the predictive values of CRP levels were poor and inferior to either cytokine, These findings may have clinical value in identifying subgroups of patients requiring different therapeutic approaches.
引用
收藏
页码:213 / 221
页数:9
相关论文
共 52 条
  • [1] HIGH IL-6 SERUM LEVELS ARE ASSOCIATED WITH SEPTIC SHOCK AND MORTALITY IN SEPTIC PATIENTS WITH SEVERE LEUKOPENIA DUE TO HEMATOLOGICAL MALIGNANCIES
    ANTONELLI, M
    RAPONI, GM
    MARTINO, P
    ROSA, G
    CONTI, G
    JALOUK, J
    GASPARETTO, A
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1995, 27 (04) : 381 - 384
  • [2] CALANDRA T, 1987, NEW ENGL J MED, V317, P1692
  • [3] HIGH CIRCULATING LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH SEPTIC SHOCK - EVOLUTION DURING SEPSIS, PROGNOSTIC VALUE, AND INTERPLAY WITH OTHER CYTOKINES
    CALANDRA, T
    GERAIN, J
    HEUMANN, D
    BAUMGARTNER, JD
    GLAUSER, MP
    [J]. AMERICAN JOURNAL OF MEDICINE, 1991, 91 (01) : 23 - 29
  • [4] PROGNOSTIC VALUES OF TUMOR-NECROSIS-FACTOR CACHECTIN, INTERLEUKIN-1, INTERFERON-ALPHA, AND INTERFERON-GAMMA IN THE SERUM OF PATIENTS WITH SEPTIC SHOCK
    CALANDRA, T
    BAUMGARTNER, JD
    GRAU, GE
    WU, MM
    LAMBERT, PH
    SCHELLEKENS, J
    VERHOEF, J
    GLAUSER, MP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (05) : 982 - 987
  • [5] ENDOGENOUS HEMATOPOIETIC GROWTH-FACTORS IN NEUTROPENIA AND INFECTION
    CEBON, J
    LAYTON, JE
    MAHER, D
    MORSTYN, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (02) : 265 - 274
  • [6] Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
    Cometta, AF
    Calandra, T
    Gaya, H
    Zinner, SH
    deBock, R
    DelFavero, A
    Bucaneve, G
    Crokaert, F
    Kern, WV
    Klastersky, J
    Langenaeken, J
    Micozzi, A
    Padmos, A
    Paesmans, M
    Viscoli, C
    Glauser, MP
    Martino, P
    Caballero, D
    Engelhard, D
    Shapiro, M
    Castagnola, E
    Massimo, L
    Giacchino, R
    Sanz, M
    Gigium, M
    Carotenuto, M
    Lopez, A
    Andrien, JM
    Paulus, R
    Martino, B
    Nobile, F
    Togni, P
    Ferster, A
    Cudillo, L
    Legrand, JC
    Dinota, A
    Cajozzo, A
    Quintini, G
    MartinezDalmau, A
    Nosari, A
    Bucaneve, GP
    Cometta, A
    Galazzo, M
    Giddey, M
    Bille, J
    Blaser, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) : 1108 - 1115
  • [7] CYTOKINE SERUM LEVEL DURING SEVERE SEPSIS IN HUMAN IL-6 AS A MARKER OF SEVERITY
    DAMAS, P
    LEDOUX, D
    NYS, M
    VRINDTS, Y
    DEGROOTE, D
    FRANCHIMONT, P
    LAMY, M
    [J]. ANNALS OF SURGERY, 1992, 215 (04) : 356 - 362
  • [8] Post hoc analyses in sepsis trials: A formula for disappointment?
    Dellinger, RP
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (05) : 727 - 729
  • [9] KINETICS AND CORRELATION WITH BODY-TEMPERATURE OF CIRCULATING INTERLEUKIN-6, INTERLEUKIN-8, TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN PATIENTS WITH FEVER AND NEUTROPENIA
    ENGEL, A
    KERN, WV
    MURDTER, G
    KERN, P
    [J]. INFECTION, 1994, 22 (03) : 160 - 164
  • [10] ENGERVALL P, 1995, EUR J HAEMATOL, V54, P226